Terug
Dagbereik
€ 13,62
€ 13,63
52-Weeksbereik
€ 6,47
€ 13,68
Volume
449.921
50D / 200D Gem.
€ 11,93
/
€ 9,24
Vorige Slotkoers
€ 13,62
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -150,2 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | -0,9 | 3,7 |
| Net Margin % | -0,4 | 3,8 |
| Rev Growth 5Y % | -1,1 | 10,0 |
| D/E | 0,9 | 0,2 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
sell | 2.793 | € 13,63 | € 38.069 |
| Mar 9, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
sell | 2.793 | € 13,63 | € 38.069 |
| Mar 7, 2026 |
Black Dylan C
General Counsel and Secretary
|
other | 2.422 | € 13,61 | € 32.963 |
| Mar 7, 2026 |
Solomon Ryan
Chief Financial Officer
|
other | 3.882 | € 13,61 | € 52.834 |
| Mar 6, 2026 |
Black Dylan C
General Counsel and Secretary
|
grant | 10.030 | € 13,61 | € 136.508 |
| Mar 6, 2026 |
Black Dylan C
General Counsel and Secretary
|
other | 3.747 | € 13,61 | € 50.997 |
| Mar 6, 2026 |
Solomon Ryan
Chief Financial Officer
|
grant | 12.859 | € 13,61 | € 175.011 |
| Mar 6, 2026 |
Solomon Ryan
Chief Financial Officer
|
other | 5.127 | € 13,61 | € 69.778 |
| Mar 6, 2026 |
Jolley Julie Diane
EVP of Home Health Operations
|
grant | 12.050 | € 13,61 | € 164.001 |
| Jan 10, 2026 |
Bolton Jeffrey
Director
|
grant | 3.761 | € 9,97 | € 37.497 |
| Jan 10, 2026 |
Rush Gregory S
Director
|
grant | 2.508 | € 9,97 | € 25.005 |
| Oct 10, 2025 |
Ohlendorf Mark W
Director
|
grant | 2.344 | € 8,00 | € 18.752 |
| Aug 5, 2025 |
Marion Tanya Renee
Chief Human Resources Officer
|
grant | 26.159 | € 6,69 | € 175.004 |
| Jul 10, 2025 |
Schochet Barry P.
Director
|
grant | 3.267 | € 7,27 | € 23.751 |
| Jul 10, 2025 |
Rush Gregory S
Director
|
grant | 3.439 | € 7,27 | € 25.002 |
| Jul 1, 2025 |
Marion Tanya Renee
Chief Human Resources Officer
|
other | 1.983 | € 7,88 | € 15.626 |
| Jul 1, 2025 |
Jolley Julie Diane
EVP of Home Health Operations
|
other | 3.032 | € 7,88 | € 23.892 |
| Jun 26, 2025 |
Bolton Jeffrey
Director
|
grant | 15.773 | € 9,51 | € 150.001 |
| Jun 26, 2025 |
Brown-Stevenson Tina L.
Director
|
grant | 15.773 | € 9,51 | € 150.001 |
| May 1, 2025 |
Abou-Oaf Ehab
Pres. Int'l Fam. Care & Prof.
|
other | 2.732 | — | — |
Belangrijkste Punten
Revenue declined -1,07% annually over 5 years
Generating 65,80M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,51%
Capital efficient — spends only 0,46% of revenue on capex
ROIC of 4,63% — low return on invested capital
Interest coverage of 1,88× — tight debt servicing
Groei
Revenue Growth (5Y)
-1,07%
Revenue (1Y)2,44%
Earnings (1Y)N/A
FCF Growth (3Y)21,06%
Kwaliteit
Return on Equity
-0,87%
ROIC4,63%
Net Margin-0,43%
Op. Margin6,02%
Veiligheid
Debt / Equity
0,94
Current Ratio1,63
Interest Coverage1,88
Waardering
P/E Ratio
-150,18
P/B Ratio1,29
EV/EBITDA17,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,44% | Revenue Growth (3Y) | 0,65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,06B | Net Income (TTM) | -4,60M |
| ROE | -0,87% | ROA | -0,39% |
| Gross Margin | 46,92% | Operating Margin | 6,02% |
| Net Margin | -0,43% | Free Cash Flow (TTM) | 65,80M |
| ROIC | 4,63% | FCF Growth (3Y) | 21,06% |
| Safety | |||
| Debt / Equity | 0,94 | Current Ratio | 1,63 |
| Interest Coverage | 1,88 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -150,18 | P/B Ratio | 1,29 |
| P/S Ratio | 0,65 | PEG Ratio | 1,05 |
| EV/EBITDA | 17,98 | Dividend Yield | 0,00% |
| Market Cap | 690,85M | Enterprise Value | 1,15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,06B | 1,03B | 1,05B | 1,07B | 1,11B |
| Net Income | -4,60M | -156,20M | -80,50M | -40,40M | 111,10M |
| EPS (Diluted) | -0,09 | -3,11 | -1,61 | 1,25 | 28,49 |
| Gross Profit | 497,30M | 504,00M | 510,70M | 545,50M | 592,70M |
| Operating Income | 63,80M | -115,10M | -47,60M | -11,40M | 142,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,17B | 1,23B | 1,43B | 1,53B | 1,72B |
| Total Liabilities | 603,00M | 672,10M | 731,90M | 751,50M | 236,70M |
| Shareholders' Equity | 534,00M | 523,50M | 669,70M | 741,70M | 1,47B |
| Total Debt | 500,00M | 569,50M | 610,10M | 625,20M | 56,90M |
| Cash & Equivalents | 43,60M | 28,40M | 27,40M | 22,90M | 5,40M |
| Current Assets | 205,60M | 192,70M | 210,10M | 211,80M | 178,80M |
| Current Liabilities | 126,30M | 126,20M | 137,70M | 132,90M | 136,50M |